BDC2.5 Mimotope 1040-63

BDC2.5 Mimotope 1040-63 is a biologically active peptide used in the investigation of type 1 diabetes (T1D), an autoimmune disease where T cells induce destruction of pancreatic islet β cells. This mimotope, originating from the TCR transgenic model (BDC2.5), facilitates the examination of antigen presentation mechanisms to islet autoantigen-specific T cells, contributing to the understanding of T cell-mediated beta-cell damage due to autoreactive T cell responses.

C([C@H](NC([C@@H](NC(=O)[C@H]1N(C([C@@H](NC([C@@H](NC([C@H](CCCNC(=N)N)N)=O)[C@@H](C)O)=O)CCCNC(=N)N)=O)CCC1)CC(C)C)=O)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CCC(O)=O)C(O)=O)=O)CCSC)=O)CCCNC(=N)N)=O)[C@H](C)C)=O)C=2C=3C(NC2)=CC=CC3